[
    [
        {
            "time": "",
            "original_text": "公司正在三期临床的新冠疫苗是哪个类型？沃森生物：是军科学院、艾博生物和公司共同合作研发的疫苗产品，属于mRNA技术路径疫苗",
            "features": {
                "keywords": [
                    "新冠疫苗",
                    "三期临床",
                    "mRNA技术",
                    "沃森生物",
                    "军科学院",
                    "艾博生物"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "公司正在三期临床的新冠疫苗是哪个类型？沃森生物：是军科学院、艾博生物和公司共同合作研发的疫苗产品，属于mRNA技术路径疫苗",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：艾博生物专业从事mRNA疫苗的开发业务",
            "features": {
                "keywords": [
                    "沃森生物",
                    "艾博生物",
                    "mRNA疫苗",
                    "开发业务"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：艾博生物专业从事mRNA疫苗的开发业务",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司目前生产上市的疫苗产品均是预防性疫苗",
            "features": {
                "keywords": [
                    "沃森生物",
                    "疫苗产品",
                    "预防性疫苗"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物：公司目前生产上市的疫苗产品均是预防性疫苗",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：公司目前共有7个疫苗产品（9个品规）生产上市销售，其中包含2个国家计划免疫规划疫苗（一类疫苗）",
            "features": {
                "keywords": [
                    "沃森生物",
                    "疫苗产品",
                    "生产上市",
                    "国家计划免疫规划疫苗",
                    "一类疫苗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沃森生物：公司目前共有7个疫苗产品（9个品规）生产上市销售，其中包含2个国家计划免疫规划疫苗（一类疫苗）",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "沃森生物：玉溪建设的疫苗厂房已经封顶",
            "features": {
                "keywords": [
                    "沃森生物",
                    "玉溪",
                    "疫苗厂房",
                    "封顶"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "沃森生物：玉溪建设的疫苗厂房已经封顶",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]